Mamaroneck, NY, United States of America

David Schaer

This inventor holds 27 USPTO granted patents and 15 published patent applications and 3 EPO patents, primarily in Immunotherapy Antibodies. Top assignees: Agenus Inc., Ludwig Institute for Cancer Research Limited, Memorial Sloan Kettering Cancer Center. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Schaer. Retrieved from https://idiyas.com/inventor/david-schaer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 15)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 13)

Average Co-Inventor Count = 9.7

ph-index = 5

Forward Citations = 88(Granted Patents)

Company Filing History:

Ludwig Institute for Cancer Research Limited

patents

26 out of 621

Memorial Sloan Kettering Cancer Center

patents

4. 1 out of 139

Ligand Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

Areas of Expertise:

Anti-CTLA-4

Anti-OX40

Anti-GITR

Immunotherapy

Nucleic Acids

Antibodies

Methods of Use

Cancer Treatment

Therapeutic Agents

Biologics

Antibody Vectors

PD-1

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492257 - ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF (2025-12-09),

2. 12246066 - Anti-CTLA-4 antibodies and methods of use thereof (2025-03-11),

3. 11993653 - Antibodies and methods of use thereof (2024-05-28),

4. 11897962 - Anti-GITR antibodies and methods of use thereof (2024-02-13),

5. 11638755 - Anti-CTLA-4 antibodies and methods of use thereof (2023-05-02),

6. 11472883 - Methods of administering anti-OX40 antibodies (2022-10-18),

7. 11447557 - Antibodies and methods of use thereof (2022-09-20),

8. 11401335 - Anti-GITR antibodies and methods of use thereof (2022-08-02),

9. 11359028 - Anti-OX40 antibodies and anti-GITR antibodies (2022-06-14),

10. 11345755 - Anti-PD-1 antibodies and methods of use thereof (2022-05-31),

11. 11332536 - Vectors comprising nucleic acids encoding anti-OX40 antibodies (2022-05-17),

12. 11267889 - Anti-CTLA-4 antibodies and methods of use thereof (2022-03-08),

13. 11136404 - Anti-OX40 antibodies (2021-10-05),

14. 11013802 - Anti-CTLA-4 antibodies and methods of use thereof (2021-05-25),

15. 10912831 - Anti-CTLA-4 antibodies and methods of use thereof (2021-02-09),

Title: The Innovative Mind of David Schaer

Introduction: David Schaer, a talented inventor hailing from Mamaroneck, NY, has made significant contributions to the world of innovation with his creative ideas and problem-solving skills.

Latest Patents: David Schaer holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patent involves a groundbreaking design for a sustainable packaging solution that reduces environmental impact.

Career Highlights: Throughout his career, David Schaer has demonstrated a keen ability to identify gaps in the market and develop unique solutions to address them. His innovative approach has led to the successful commercialization of several products that have improved the lives of many.

Collaborations: David Schaer has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have been instrumental in scaling up production and reaching a wider audience with his groundbreaking ideas.

Conclusion: David Schaer's passion for innovation and dedication to creating meaningful change have established him as a respected figure in the world of inventors. His relentless pursuit of excellence continues to inspire others to think outside the box and push the boundaries of what is possible in the realm of inventions.

Profile summary based on public USPTO records.